Company intelligence / Profile preview

ABS Bio

Delaware, United Statesabsbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

ABS Bio is a leading provider of human biospecimens, biostorage solutions, and cell culture services for the global biopharma industry. With over 30 years of experience since its founding in 1990, the company supports research by supplying high-quality biological materials and laboratory support to pharmaceutical companies and academic researchers. It is recognized for its scientific rigor, quality control protocols, and customer-centric approach.

Modalities: Human biospecimens (cells, tissues, DNA, RNA)Cell culture services
Industry: Drug Discovery Services

Partnerships

Strategic investment by 3 Boomerang Capital

Beyond the preview

Go deeper on ABS Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABS Bio.

Explore the full profile